Kevin M. Slawin - Net Worth and Insider Trading
Kevin M. Slawin Net Worth
The estimated net worth of Kevin M. Slawin is at least $5,810 dollars as of 2024-11-12. Kevin M. Slawin is the Director of Bellicum Pharmaceuticals Inc and owns about 77,726 shares of Bellicum Pharmaceuticals Inc (BLCM) stock worth over $5,810. Details can be seen in Kevin M. Slawin's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Kevin M. Slawin has not made any transactions after 2017-02-07 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Kevin M. Slawin
Kevin M. Slawin Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Kevin M. Slawin owns 2 companies in total, including Bellicum Pharmaceuticals Inc (BLCM) , and Arbor Rapha Capital Bioholdings Corp I (ARCK) .
Click here to see the complete history of Kevin M. Slawin’s form 4 insider trades.
Insider Ownership Summary of Kevin M. Slawin
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| BLCM | Bellicum Pharmaceuticals Inc | 2017-02-07 | director & CMO and CTO |
| ARCK | Arbor Rapha Capital Bioholdings Corp I | 2021-10-28 | director & Chief Strategy Officer |
Kevin M. Slawin Latest Holdings Summary
Kevin M. Slawin currently owns a total of 1 stock. Kevin M. Slawin owns 77,726 shares of Bellicum Pharmaceuticals Inc (BLCM) as of February 7, 2017, with a value of $5,810.
Latest Holdings of Kevin M. Slawin
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| BLCM | Bellicum Pharmaceuticals Inc | 2017-02-07 | 77,726 | 0.07 | 5,810 |
Holding Weightings of Kevin M. Slawin
Kevin M. Slawin Form 4 Trading Tracker
According to the SEC Form 4 filings, Kevin M. Slawin has made a total of 0 transactions in Bellicum Pharmaceuticals Inc (BLCM) over the past 5 years. The most-recent trade in Bellicum Pharmaceuticals Inc is the sale of 3,000 shares on February 7, 2017, which brought Kevin M. Slawin around $376,200.
Insider Trading History of Kevin M. Slawin
- 1
Kevin M. Slawin Trading Performance
Kevin M. Slawin Ownership Network
Ownership Network List of Kevin M. Slawin
Ownership Network Relation of Kevin M. Slawin
Kevin M. Slawin Owned Company Details
What does Bellicum Pharmaceuticals Inc do?
Who are the key executives at Bellicum Pharmaceuticals Inc?
Kevin M. Slawin is the director & CMO and CTO of Bellicum Pharmaceuticals Inc. Other key executives at Bellicum Pharmaceuticals Inc include Chief Development Officer Charity Scripture , Principal Accounting Officer Charles S. Grass , and director & President and CEO Richard A. Fair .
Bellicum Pharmaceuticals Inc (BLCM) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Bellicum Pharmaceuticals Inc (BLCM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Bellicum Pharmaceuticals Inc (BLCM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Bellicum Pharmaceuticals Inc (BLCM)'s detailed insider trading history can be found in Insider Trading Tracker table.
Bellicum Pharmaceuticals Inc Insider Transactions
Kevin M. Slawin Mailing Address
Above is the net worth, insider trading, and ownership report for Kevin M. Slawin. You might contact Kevin M. Slawin via mailing address: C/o Bellicum Pharmaceuticals, Inc., 2130 W. Holcombe Blvd., Ste. 800, Houston Tx 77030.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
